학술논문
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Document Type
Original Paper
Author
Gorfinkel, Lev; Raghunandan, Sharmila; Watkins, Benjamin; Hebert, Kyle; Neuberg, Donna S.; Bratrude, Brandi; Betz, Kayla; Yu, Alison; Choi, Sung W.; Davis, Jeffrey; Duncan, Christine; Giller, Roger; Grimley, Michael; Harris, Andrew C.; Jacobsohn, David; Lalefar, Nahal; Farhadfar, Nosha; Pulsipher, Michael A.; Shenoy, Shalini; Petrovic, Aleksandra; Schultz, Kirk R.; Yanik, Gregory A.; Blazar, Bruce R.; Horan, John T.; Langston, Amelia; Kean, Leslie S.; Qayed, Muna
Source
Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 59(5):680-687
Subject
Language
English
ISSN
0268-3369
1476-5365
1476-5365
Abstract
Chronic graft-versus-host-disease (cGVHD) is divided into two subtypes: classic (absence of acute GVHD features) and overlap cGVHD (‘ocGVHD’), in which both chronic and acute GVHD clinical features are present simultaneously. While worse outcomes with ocGVHD have been reported, there are few recent analyses. We performed a secondary analysis of data from the ABA2 trial (N = 185), in which detailed GVHD data were collected prospectively and systematically adjudicated. Analyses included cumulative incidence of classic versus ocGVHD, their specific organ manifestations, global disease severity scores, non-relapse mortality (NRM), disease-free survival (DFS) and overall survival (OS) in these two cGVHD subtypes. Of 92 patients who developed cGVHD, 35 were classified as ocGVHD. The 1-year cumulative incidence, organ involvement, and global severity of classic and ocGVHD were similar between ABA2 patients receiving CNI/MTX+placebo and CNI/MTX+abatacept; thus, cohorts were combined for ocGVHD evaluation. This analysis identified ocGVHD as having significantly higher severity at presentation and at maximum global severity compared to classic cGVHD. OS and DFS were significantly lower for ocGVHD versus classic cGVHD. OcGVHD is associated with increased cGVHD severity scores, and is associated with decreased OS and DFS compared to classic cGVHD, underscoring the high risks with this cGVHD subtype.